Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report

被引：0
|
作者：
Enrique Rey
Fermín Mearin
Javier Alcedo
Constanza Ciriza
Silvia Delgado-Aros
Teresa Freitas
Miguel Mascarenhas
Miguel Mínguez
Javier Santos
Jordi Serra
机构：
[1] Hospital Universitario Clínico de San Carlos,Division of Digestive Diseases
[2] Instituto de Investigacion San Carlos (IdISSC),Department of Medicine
[3] School of Medicine,Institute of Functional and Motor Digestive Disorders
[4] Complutense University,Division of Digestive Diseases
[5] Centro Médico Teknon,Division of Digestive Diseases
[6] Hospital Universitario Miguel Servet,Institut Hospital del Mar d’Investigacions Mèdiques (IMIM)
[7] Hospital Universitario Doce de Octubre,Division of Digestive Diseases
[8] Neuro-Enteric Translational Science (NETS) Research Group,Digestive System Research Unit, Laboratory of Neuro
[9] Centro Hospitalar Vila Nova de Gaia,Immuno
[10] CUF Porto Hospital,Gastroenterology
[11] Hospital Clínic,Department of Gastroenterology
[12] Universitat of Valencia,Department of Medicine
[13] Valld’Hebron Institut de Recerca VHIR,Motility and Functional Gut Disorders Unit
[14] Hospital Universitari Vall d’Hebron,undefined
[15] Universitat Autònoma de Barcelona,undefined
[16] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd),undefined
[17] University Hospital Germans Trias i Pujol,undefined
来源：
Advances in Therapy | 2017年 / 34卷
关键词：
Abdominal pain; Bloating; Constipation; Constipation-predominant irritable bowel syndrome; Gastroenterology; Linaclotide; Patient management; Recommendations;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：587 / 598
页数：11
相关论文
共 50 条
  • [31] Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation
    Eswaran, Shanti
    Guentner, Amanda
    Chey, William D.
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 20 (02) : 141 - 151
  • [32] Durability and Predictability of Treatment Response to Lubiprostone in Patients With Constipation-Predominant Irritable Bowel Syndrome
    Fass, Ronnie
    Chey, William D.
    Wang, Martin
    Mareya, Shadreck
    Losch-Beridon, Taryn
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S761 - S761
  • [33] Cisapride treatment of constipation-predominant irritable bowel syndrome is not superior to placebo
    Ziegenhagen, DJ
    Kruis, W
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (07) : 744 - 749
  • [34] Potential effects of sodium hyaluronate on constipation-predominant irritable bowel syndrome
    Cui, Li
    Zou, Shuting
    Liu, Jing
    Lv, Huixia
    Li, Hui
    Zhang, Zhenhai
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 127
  • [35] Constipation-Predominant Irritable Bowel Syndrome Complicating Asymptomatic Nonrotation of the Midgut
    Plackett, Timothy P.
    Myers, Jonathan
    Gagliano, Ronald A., Jr.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2010, 110 (08): : 437 - 440
  • [36] Long-term safety of tegaserod in patients with constipation-predominant irritable bowel syndrome
    Tougas, G
    Snape, WJ
    Otten, MH
    Earnest, DL
    Langaker, KE
    Pruitt, RE
    Pecher, E
    Nault, B
    Rojavin, MA
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (10) : 1701 - 1708
  • [37] Current and future pharmacotherapies for the management of constipation-predominant irritable bowel syndrome
    Biniszewska, Olga
    Jacenik, Damian
    Tarasiuk, Aleksandra
    Fichna, Jakub
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (08) : 1039 - 1049
  • [38] Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review
    Mosinska, Paula
    Salaga, Maciej
    Fichna, Jakub
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (03) : 275 - 286
  • [39] Colchicine Plus Olsalazine for Treatment of Constipation-Predominant Irritable Bowel Syndrome
    Barody, Thomas J.
    Hills, Lauren A.
    Torres, Margaux
    GASTROENTEROLOGY, 2009, 136 (05) : A484 - A484
  • [40] Abnormal colonic propagated activity in patients with slow transit constipation and constipation-predominant irritable bowel syndrome
    Bassotti, G
    Chistolini, F
    Marinozzi, G
    Morelli, A
    DIGESTION, 2003, 68 (04) : 178 - 183
12345